Valeo Financial Advisors, LLC Axonics, Inc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$51.39 - $66.9 $92,553 - $120,486	-1,801 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$35.33 - $51.04 $102,845 - $148,577	-2,911 Reduced 61.78%	1,801 $92,000
Q2 2020 Jul 20, 2020	BUY	$22.91 - $39.83 $66,691 - $115,945	2,911 Added 161.63%	4,712 $165,000
Q4 2019 Jan 24, 2020	BUY	$19.57 - $28.96 $19,178 - $28,380	980 Added 119.37%	1,801 $50,000
Q3 2019 Oct 15, 2019	BUY	$26.92 - $42.41 $1,022 - $1,611	38 Added 4.85%	821 $22,000
Q2 2019 Jul 10, 2019	BUY	$18.54 - $40.97 $14,516 - $32,079	783 New	783 $32,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.